Insulin Resistance Test: HOMA-IR, OGTT & Blood Markers

Insulin Resistance Test: Which Values Really Matter

Do you often feel tired after lunch, gain weight around your abdomen despite exercising and eating consciously, or experience unexplained cravings for sweets? These symptoms could be more than everyday stress. They can, among other things, be associated with insulin resistance, a metabolic disorder that can remain unnoticed for a long time and may increase the risk of type 2 diabetes, cardiovascular disease, and other chronic conditions.

The problem: A simple fasting blood glucose test, as commonly performed by a general practitioner, can still appear normal despite developing insulin resistance. A more comprehensive insulin resistance test therefore looks more closely. It measures not just glucose, but also your body’s insulin response.

This article explains precisely and without unnecessary jargon which blood values really matter, how they can be interpreted, and which testing methods are available, from simple blood tests to comprehensive diagnostics at a specialized clinic such as YEARS.

What Is Insulin Resistance – and Why Is Testing Important?

Insulin resistance means that your body’s cells no longer respond properly to the hormone insulin. Insulin helps transport glucose from the blood into cells, where it can be used for energy. When cells become resistant to insulin, the pancreas has to produce more insulin to keep blood glucose levels stable. This state of elevated insulin levels is known as hyperinsulinemia and is a typical feature of insulin resistance.

Why Fasting Blood Glucose Alone Is Not Enough

For years, the pancreas can compensate for increasing insulin resistance. Your fasting blood glucose remains within the normal range because higher insulin production can still regulate glucose effectively. As a result, a standard laboratory report may initially look completely normal.

As beta-cell function progressively declines, compensatory insulin secretion may eventually become insufficient and blood glucose begins to rise. This can first lead to prediabetes and later to type 2 diabetes. An early insulin resistance test that also measures insulin can provide indications of this development considerably earlier.

How Many People Are Affected?

Insulin resistance is not a rare metabolic disorder. Its exact prevalence is difficult to determine because definitions, testing methods, and thresholds vary between studies. What is clear is that metabolic dysfunction becomes considerably more common with increasing age and with factors such as excess weight, physical inactivity, and visceral fat. Early diagnostics can therefore be an important part of prevention.

Which Tests Are Available for Insulin Resistance?

Reliably assessing insulin resistance requires more than a single measurement. Different tests and biomarkers together provide a much clearer picture of your metabolic health. The scientific gold standard for directly measuring insulin sensitivity, the hyperinsulinemic-euglycemic clamp, is highly complex and is mainly used in research. In clinical practice, however, several well-established surrogate markers and challenge tests are available.

HOMA-IR: An Important Calculated Marker

The Homeostasis Model Assessment of Insulin Resistance, or HOMA-IR, is one of the most commonly used and best-studied surrogate markers for estimating insulin resistance. It is calculated using two simple blood measurements taken in the morning after fasting:

• Fasting blood glucose (mg/dL)
• Fasting insulin (µU/mL)

The formula is:

HOMA-IR = (fasting insulin × fasting blood glucose) / 405

A high HOMA-IR indicates that your body requires comparatively large amounts of insulin to maintain a given blood glucose level.

OGTT: The Dynamic Challenge Test

The oral glucose tolerance test, or OGTT, shows how your body responds to a glucose challenge. You drink a standardized solution containing 75 grams of glucose, and your blood glucose and – in an extended assessment – insulin levels are measured several times over two hours, for example at baseline, after 60 minutes, and after 120 minutes.

A simple blood glucose measurement provides only a snapshot. The OGTT instead shows how your metabolism handles a defined glucose load.

Additional insulin measurements can provide particularly valuable information. They show how much insulin your pancreas needs to release to manage the glucose challenge. A pronounced rise in insulin or insulin levels that remain elevated for longer can indicate reduced insulin sensitivity, even when glucose values are still within normal ranges. However, there are currently no universally accepted clinical thresholds for interpreting the insulin curve.

You can find more information about this method in our detailed article on the oral glucose tolerance test (OGTT).

Fasting Insulin: The Often-Missing Marker

Fasting insulin is one of the particularly interesting blood markers when assessing insulin resistance. It can already be elevated while fasting blood glucose remains within the normal range. Elevated fasting insulin may indicate compensatory hyperinsulinemia and is used together with fasting glucose to calculate HOMA-IR.

It is rarely measured routinely in primary care.

HbA1c: Long-Term Blood Glucose

HbA1c provides an approximate indication of average blood glucose levels over the previous eight to twelve weeks. It is an established marker for diagnosing and monitoring diabetes. For detecting isolated insulin resistance at an early stage, however, it has limitations because increased insulin secretion can initially compensate for rising glucose levels.

An HbA1c of 5.7 to 6.4% already falls within the prediabetes range according to commonly used international criteria and should be interpreted accordingly.

Overview: The Most Important Tests for Insulin Resistance

What Do the Values Mean? How to Interpret HOMA-IR

HOMA-IR is a useful tool, but it needs to be interpreted correctly. There is no single universally accepted clinical cutoff. Thresholds vary depending on the study, population, age, sex, and the insulin assay used.

As a rough guide, studies frequently use values around approximately 2.0 to 2.5 as a threshold range for reduced insulin sensitivity (Matthews et al., Diabetologia 1985; Gayoso-Diz et al., BMC Endocrine Disorders 2013).

A lower HOMA-IR generally indicates higher insulin sensitivity, while a clearly elevated value may suggest insulin resistance. However, interpretation should always take into account fasting insulin, glucose levels, body composition, other metabolic biomarkers, and, where appropriate, an OGTT.

Typical Symptoms Associated With Abnormal Values

If your insulin resistance blood markers are abnormal, you may also recognize some of the following physical signs:

• Persistent fatigue, particularly after carbohydrate-rich meals
• Difficulty losing weight, especially around the abdomen, or increased visceral fat
• Strong cravings for sugar or carbohydrates
• Difficulty concentrating or “brain fog”
• Skin changes such as acanthosis nigricans, meaning dark, velvety discoloration in skin folds

These symptoms are nonspecific and can have many other causes. However, in combination with abnormal metabolic blood markers, they may be a reason to investigate further.

Testing for Insulin Resistance: Where and How?

There are several ways to have your insulin resistance assessed. Each has advantages and disadvantages.

1. Through Your General Practitioner

As part of routine health screening, fasting glucose and lipid markers such as total cholesterol, LDL, HDL, and triglycerides are commonly measured.

Fasting insulin, and therefore calculation of HOMA-IR, is generally not part of routine screening. If there is a medical indication, additional testing may be performed. Depending on the healthcare system and provider, fasting insulin may also be available as a self-pay test.

2. Through a Private Physician or Check-Up Clinic

Private physicians and specialized preventive medicine clinics often offer more comprehensive laboratory testing that includes fasting insulin and additional metabolic biomarkers. Depending on insurance coverage, medical indication, and the specific plan, reimbursement may be possible.

For self-paying patients, these assessments can provide a considerably more complete picture of metabolic health than standard primary-care screening.

3. At-Home Test Kits

Some providers offer tests that can be ordered online and completed using a sample collected at home and sent to a laboratory. Depending on the provider, glucose, HbA1c, and other metabolic markers may be measured.

Which parameters can be measured reliably depends on the sample material, collection method, and laboratory procedure. Many home tests also lack medical interpretation within the wider context of your health, family history, and other biomarkers. An isolated value therefore provides only part of the picture.

4. Comprehensive Diagnostics at YEARS

An effective approach is to assess insulin resistance blood markers as part of a comprehensive health evaluation. In the YEARS Core® program, an oral glucose tolerance test with both glucose and insulin measurements is a standard component.

This allows us to calculate HOMA-IR while also creating a dynamic picture of your glucose and insulin metabolism under metabolic stress. The additional insulin measurements can reveal changes that might remain unnoticed if glucose is assessed alone.

We also analyze more than 87 biomarkers, including hs-CRP as an inflammatory marker and a detailed lipid profile including ApoB. This combination allows our physicians to assess insulin resistance within the context of your overall metabolic and cardiovascular risk profile.

What Can You Do About Insulin Resistance? First Steps

Insulin resistance can often be significantly improved through lifestyle interventions. Identifying it early gives you an opportunity to specifically reduce your risk of developing type 2 diabetes. The evidence clearly supports several particularly relevant measures:

• Nutrition: A diet low in highly processed foods, added sugar, and sugar-sweetened beverages, while rich in fiber from vegetables, legumes, and whole grains, can support metabolic health. Healthy fats from nuts, seeds, and olive oil, together with sufficient protein, can also form part of such a diet (Forouhi et al., BMJ 2018). For people with excess weight, sustainable weight loss and particularly a reduction in visceral fat are among the most effective ways to improve insulin sensitivity.
• Exercise: Both endurance training and resistance training have been shown to improve insulin sensitivity. Skeletal muscle plays a central role in glucose uptake from the bloodstream. Greater muscle mass and regular muscle activity therefore support metabolic regulation. There is also strong evidence linking higher cardiorespiratory fitness with a lower risk of metabolic disease (Laaksonen et al., Diabetes Care 2002). At YEARS, we measure VO₂max using cardiopulmonary exercise testing to help guide your training more precisely.
• Monitoring: After abnormal findings, it can be useful to reassess insulin resistance markers over time. When HOMA-IR, fasting insulin, or another OGTT should be repeated depends on the initial findings and the interventions that have been implemented. Our article on which blood markers are useful from age 30 provides more information on general preventive blood testing.

Detecting Insulin Resistance Early: Which Test Is Right for Whom?

Identifying insulin resistance before blood glucose becomes clearly abnormal can be an important component of preventing metabolic disease.

• A normal fasting blood glucose level does not rule out insulin resistance.
• HOMA-IR, calculated using fasting glucose and fasting insulin, is an easily accessible marker for an initial assessment of insulin sensitivity.
• The oral glucose tolerance test shows how your body handles a defined glucose challenge. Additional insulin measurements provide valuable information about how much insulin your body needs to maintain glucose control.

If you want to understand your metabolism within the wider context of your health, comprehensive diagnostics can provide a much clearer picture. The YEARS Core® program offers exactly that: within a single day, the OGTT, expanded laboratory panel, and medical interpretation provide a precise baseline of your metabolic health and a clear plan for the next steps.

Don’t wait for symptoms.

Sources

• Demuth, I., Steinhagen-Thiessen, E., & Norman, K. (2021). The relevance of the metabolic syndrome in the oldest old: a study in 1572 participants of the Berlin Aging Study II (BASE-II). Journal of Cachexia, Sarcopenia and Muscle, 12(6), 1989–1996.
• Forouhi, N. G., Misra, A., Mohan, V., Taylor, R., & Yancy, W. (2018). Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ, 361, k2234.
• Gayoso-Diz, P., Otero-González, A., Rodriguez-Alvarez, M. X., Gude, F., García, F., De Francisco, A., & Ojea, R. (2013). Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age. BMC Endocrine Disorders, 13, 47.
• Laaksonen, D. E., Lakka, H. M., Salonen, J. T., Niskanen, L. K., Rauramaa, R., & Lakka, T. A. (2002). Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care, 25(9), 1612–1618.
• Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412–419.